Sunvozertinib: Best-in-Class for NSCLC EGFR Exon20ins Mutation Lung 1 Min Read7 Caicun Zhou, MD, PhD – Tongji University Shanghai Pulmonary Hospital Sunvozertinib established itself as the leading targeted therapy for NSCLC…
